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Background: Intraoperative arterial hypotension can lead to severe complications in patients undergoing carotid
endarterectomy, in particular if cerebral auto-regulation is impaired. Short-acting agents, such as phenylephrine or
ephedrine, commonly used to correct intra-operative hypotension, have different hemodynamic effects. Recently, it
was reported that, in healthy anesthetized subjects with intact cerebral auto-regulation, frontal lobe cerebral tissue
oxygenation declined after phenylephrine bolus administration, while it was preserved after ephedrine use (Br J
Anaesth 107:209–217, 2011; Neurocrit Care 12:17–23, 2010). However, the effect of both agents in patients
undergoing carotid endarterectomy is unknown. The aim of this study is to assess the effect of two routinely used
vasopressors (phenylephrine and ephedrine) on the cerebral hemodynamics during carotid endarterectomy.
Methods/design: Patients undergoing carotid endarterectomy will be prospectively included and randomized for
correction of intraoperative hypotension with either phenylephrine (50 to 100 μg) or ephedrine (5 to 10 mg). If
hypotension persists for more than five minutes after treatment, the patient will be classified as a non-responder
and escape medication as preferred by the anesthesiologist will be administered. Changes in cerebral
hemodynamics will be quantified by changes in transcranial Doppler-derived middle cerebral artery blood velocity
and near infra-red spectroscopy-derived frontal lobe cerebral tissue oxygenation, when intra-operative hypotension
is treated with phenylephrine or ephedrine in patients who undergo carotid endarterectomy with or without an
adequate functioning cerebral auto-regulation.
To quantify whether the intra-operative cerebral auto-regulation is impaired or not, a decrease in breathing
frequency from the normal 12 breaths per minute to 6 breaths per minute for an episode of three minutes will be
performed.
Discussion: Phenylephrine and ephedrine are two of the most commonly used short-acting agents to increase
blood pressure in clinical anesthesiologic practice. Monitoring of middle cerebral artery blood velocity with
transcranial Doppler and frontal lobe cerebral tissue oxygenation with near infra-red spectroscopy are part of the
standard of care. Furthermore, there are no reports that the three-minute modification in breathing frequency
described in the “intervention”-section is harmful. Therefore, the risks for participating patients are negligible and
the burden minimal.
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Carotid endarterectomy (CEA) is the recommended
treatment to prevent future cardiovascular events in
patients with a symptomatic high degree stenosis of the
internal carotid artery (ICA). Besides these symptoms,
stenosis of the ICA jeopardizes the cerebral perfusion
and may affect cerebral auto-regulation (CA), indicating
that cerebral perfusion becomes dependent on changes
in blood pressure [1]. Therefore, to preserve cerebral
perfusion during surgery and to prevent ‘watershed’
stroke, intraoperative hypotension needs to be avoided
and the suggested blood pressure that should be main-
tained intraoperatively is an arterial pressure between
baseline blood pressure measured on the nursing ward
the day before surgery and 20% above this blood pres-
sure [2].
To do so, different short-acting vasopressor agents can
be used, such as phenylephrine or ephedrine [3]. If exist-
ing at all, preference for either of these agents is solely
based on the discretion of the attending anesthesiologist.
Furthermore, ephedrine and phenylephrine are widely
accepted and, when heart rate is in the normal range,
applied in cardiovascular surgery on the basis of individ-
ual preference. Both agents have a different mechanism
of action. Phenylephrine (an α-agonist) increases blood
pressure purely by vasoconstriction, whereas ephedrine
(a combined α- and β-agonist) increases blood pressure
by a combination of vasoconstriction and an increase in
heart rate and a subsequent rise in cardiac output [4].
Besides the difference in systemic hemodynamics, the
perfusion of the brain reacts differently. In healthy sub-
jects, with intact CA, the frontal lobe cerebral tissue
oxygenation (rSO2) decreases during phenylephrine ad-
ministration while it is preserved with ephedrine use
[4,5]. It is suggested that the increase in cardiac output
observed during ephedrine use can explain this differ-
ence in rSO2 [5]. It is unknown how in the situation of
impaired CA, as often observed in patients undergoing a
CEA, the rSO2 and vasomotor tone react after adminis-
tration of phenylephrine or ephedrine. Thus, the optimal
drug to maintain cerebral perfusion in CEA patients,
with an impaired CA is unknown. If during the use of
one of the two agents cerebral perfusion would be better
maintained or even increased this would clearly influ-
ence the choice for the desired agent.
In our institution, we routinely monitor rSO2 using
near infrared spectroscopy (NIRS) and middle cerebral
artery blood velocity (VMCA) measured by transcranial
Doppler (TCD) during CEA. To study the effect of both
vasopressors on these parameters, we retrospectively
analyzed the effect of phenylephrine and ephedrine
induced changes in mean arterial pressure (MAP) on
rSO2 and VMCA in 11 CEA patients. We noticed that
phenylephrine and ephedrine both increased MAP andVMCA in patients undergoing carotid endarterectomy.
However, an increase in MAP induced by phenylephrine
has a lowering effect on the rSO2, while ephedrine had
an increasing effect on the rSO2 [6].
This pilot study indicated that the use of ephedrine
should be preferred above the use of phenylephrine for
correction of hypotension during CEA. However, the
numbers of patients were small and the dose of agent
applied not standardized. Therefore, a prospective study
to analyze the effect of both ephedrine and phenyleph-




Our primary objective is to study the influence of
two routinely used drugs to increase MAP (phenyl-
ephrine and ephedrine) on cerebral oxygenation and
perfusion, estimated by changes in NIRS derived rSO2
and TCD derived VMCA, in patients undergoing carotid
endarterectomy.
Our secondary objective is to evaluate whether the in-
fluence of phenylephrine and ephedrine on cerebral per-
fusion and oxygenation is different between patients
with and without an adequate functioning CA.
Study design
Participants
This study is designed as a prospective randomized trial
in a tertiary referral vascular center.
The study population will include all patients indicated
for CEA because of a symptomatic high degree stenosis
of the ICA (discussed in a multidisciplinary meeting) in
the University Medical Centre Utrecht (UMCU) who
needs use of vasopressor to increase MAP during CEA
[Figure 1].
To be included in the current study all patients must
meet the following criteria:
1. Undergoing CEA because of a symptomatic high
degree stenosis of the ICA in the University Medical
Centre Utrecht.
2. Having an appropriate temporal bone window for
reliable peri-operative TCD monitoring.
3. Having given written informed consent.
4. Having a decrease in MAP >20% during surgery.
Patients will be excluded if they meet one of the fol-
lowing criteria:
1. Not having a temporal bone window appropriate for
TCD measurement.
2. Not willing to give informed consent.
3. No decrease in MAP >20%.
Figure 1 Study protocol flow chart.
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time of administration.
5. Hypersensitivity to either ephedrine of phenylephrine.Randomization and interventions
This study is designed as a prospective randomized trial
in a tertiary referral vascular center. Currently, the pre-
ference of administering either phenylephrine or ephe-
drine for correction of intraoperative hypotension is
mainly based on the physician’s preferences. For this trial
randomization based on a computer-generated random-
ization list will be performed during CEA to counteract
changes in MAP more than 20% under baseline with
either
1) Phenylephrine (50 to 100 μg), or
2) Ephedrine (5 to 10 mg),
If hypotension persists five minutes after adminis-
tration of the randomized medication, this patient
will be classified as a non-responder and escape
medication as preferred by the anesthesiologist will be
administered.
Before surgery all patients will be informed about the
trial procedure. Written informed consent will be
obtained from all patients.
As part of the standard of care cerebral monitoring,
including transcranial Doppler (TCD), Near Infrared
Spectroscopy (NIRS) and electroencephalography (EEG)
will be provided. To quantify whether the intra-
operative cerebral auto-regulation is impaired or not, the
breathing frequency will be decreased from the normal
12 breaths per minute to 6 breaths per minute for an
episode of three minutes.Study parameters
Our primary study parameters are the changes in rSO2
measured using NIRS and VMCA measured using TCD.
Our secondary parameter is quantification of cerebral
auto-regulation.
Sample size calculation
To determine the sample size, we conducted a power
analysis based on a retrospective pilot study. In this pilot
study (performed in the UMCU), the response within
each subject group was normally distributed. After
phenylephrine administration a decrease in rSO2 of
−1.5% (± 2) per 10 mmHg increase was seen, while after
ephedrine use the rSO2 increased 1% (± 2) per 10
mmHg increase. We calculated that 14 patients in each
group would be required to reject the null hypothesis
that the population means of the experimental and con-
trol groups are equal with probability (power) 0.9. The
Type I error probability associated with this test of this
null hypothesis is 0.05. Adjusting the sample size to drop
out of patients (because of bad signal quality, medical
reasons), 20 patients per group will be sufficient.
In our vascular center, CEA is performed weekly. We
assume two patients can be included weekly. Therefore,
the estimated length of the study will be approximately
six months.
Medication
Ephedrine is a sympathomimetic amine acting directly
on the alpha and β-receptors and indirectly by increas-
ing the release of norepinephrine by the sympathetic
nerve endings. As with any sympathomimetic agent,
ephedrine stimulates the central nervous system, the
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sphincters of the digestive and urinary tract. After intra-
venous administration, ephedrine is completely biologic-
ally available. Intravenous injections are effective within
a minute and for up to about 20 minutes. Small quan-
tities of ephedrine are metabolized in the liver, but the
majority of ephedrine is excreted unchanged in the
urine. Elimination of ephedrine is increased (and hence
the half-life is decreased) with decreasing pH of the
urine.
Phenylephrine hydrochloride is a sympathomimetic
agent with mainly direct effects on adrenergic receptors.
It has predominantly α-adrenergic activity and is without
significant stimulating effects on the central nervous sys-
tem at usual doses. After injection it produces peripheral
vasoconstriction and increased arterial pressure. It also
causes a baro-reflex mediated bradycardia. Intravenous
injections are effective within a minute and for up to
about 20 minutes. Phenylephrine is metabolized in the
liver by monoamine oxidase. The metabolites, their
route and rate of excretion have not been identified.
For both ephedrine and phenylephrine the preparation
and labeling will be conducted as in the pharmacy de-
partment of the UMC Utrecht. The investigational pro-
ducts are part of the standard of care and, therefore,
received, stored and disposed at the pharmacy of the
University Medical Center Utrecht.
Intraoperative care
Anesthesia (no deviation of standard of care)
Following connection of the patient to the anesthesia
monitor, an intra-arterial catheter in the radial artery is
placed in each patient for arterial blood pressure meas-
urement. Induction of anesthesia is achieved with sufen-
tanil (0.3 to 0.7 mcg/kg) and propofol (0.5 to 2.0 mg/kg).
Rocuronium (0.3 to 0.5 mg/kg) is used to facilitate tra-
cheal intubation. Anesthesia is maintained using the
volatile anesthetic sevoflurane, aiming at a Minimum Al-
veolar Concentration (MAC) value of 0.5 to 1.
Anesthesia-related hypotension is treated with either
phenylephrine or ephedrine administration (study medi-
cation). In case hypotension persists five minutes after
administration of either ephedrine or phenylephrine, the
patient will be classified as a non-responder and escape
medication as preferred by the anesthesiologist will be
administered. Outside the study period, the choice of
treatment to correct hypotension will be based on the
physician’s preferences. After heparinization, MAP is
maintained between −10% and +10% from baseline, until
carotid artery cross clamping is performed. At the end
of the procedure, the sevoflurane supply will be stopped,
and after return of spontaneous respiration, the trachea
will be extubated and the patient will be transferred to
the recovery ward.Measurement of cerebral auto-regulation
To quantify whether the intra-operative CA is impaired
or not, the breathing frequency is decreased from the
normal 12 breaths per minute to 6 breaths per minute
for an episode of three minutes. To maintain an un-
changed minute alveolar ventilation of approximately six
liters per minute, the tidal volume has to be almost
doubled. The intra-thoracic pressure oscillations created
with this way of ventilating will be transferred to the ar-
terial blood pressure signal since a higher intra-thoracic
pressure during mechanical insufflation of the lungs will
prohibit blood from entering the thoracic cavity. Ap-
proximately two heartbeats after the start of the inspir-
ation the amount of blood delivered to the right side of
the heart decreases and also the amount of blood leaving
the left side of the heart (that is, cardiac output)
declines. In the expiration phase the opposite occurs and
cardiac output increases. This variation in cardiac output
results in a concomitant oscillation in the beat-to-beat
registered blood pressure and this is again transferred to
the beat-to-beat VMCA and rSO2 signals.
Intact CA implies that the cerebral perfusion remains
constant despite changes in blood pressure. Hypothetic-
ally, this means that the VMCA would remain totally un-
altered despite the 6 per minute blood pressure
oscillations as elicited with the ventilator in anesthetized
subjects. In reality, CA behaves like a high pass filter.
This means that oscillations with a duration of 10 sec-
onds in blood pressure will be present but dampened in
the VMCA signal. Furthermore, oscillations in VMCA in
this frequency area precede those in MAP by approxi-
mately two to three seconds. The better CA functions
the more the amplitude of the oscillation in VMCA will
be dampened and the more the VMCA signal precedes
the blood pressure signal.
Intraoperative monitoring (no deviation of standard of care)
Blood pressure monitoring
A radial artery catheter is placed in each patient for con-
tinuous blood pressure measurement.
Cardiac output monitoring:
Noninvasive arterial pressure (NAP) will be measured
using the Nexfin monitor (BMEYE B.V., Amsterdam,
The Netherlands), which uses an improved finger cuff
technology with high sensitivity optical components and
fully digital control systems. In addition, brachial arterial
blood pressure is reconstructed from the measured fin-
ger arterial pressure using waveform filtering to approxi-
mate a brachial pressure wave, together with pressure
level correction compensating for the finger to radial
pressure difference. An appropriate size finger cuff will
be applied to the mid-phalanx of the middle finger ipsi-
laterally to the invasive blood pressure catheter. The
“heart reference system”, which measures and corrects
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heart, will be set at the arterial pressure transducer level.
Near-infrared spectroscopy
Bilateral rSO2 measurements will be performed using
Invos Cerebral Oximeter (Somanetics Corporation, Troy,
MI, USA), which allows continuous monitoring of cere-
bral oxygenation, by penetrating the scalp and brain
tissue whereby the skin, scull and other tissues are rela-
tively transparent to near-infrared wavelengths of light.
Changes in concentrations of oxygenated and deoxygenated
hemoglobin are measured by a modified Beer-Lambert
method and because of the different wavelengths of the
oxygenated and deoxygenated hemoglobin, these can be
distinguished and the ratio of oxygenated hemoglobin
to total tissue hemoglobin (TOI) can be defined. By
using two detectors the light reflected and transmitted
by the superficial extracranial tissues is subtracted.
TCD measurement
For all TCD registrations a pulsed Doppler transducer
(DWL Multidop X4, Sipplingen, Germany) gated at a
focal depth of 45 to 60 mm, will be placed over the tem-
poral bone to insonate the main stem of the ipsilateral
middle cerebral artery and the contralateral anterior
cerebral artery.
After tracheal intubation, TCD is applied. The TCD
probes are fitted in a light metal frame, which is firmly
fixed to the head with two earpieces and an adjustable
nose saddle. The VMCA, will be measured continuously.
EEG measurement
For measuring the cerebral function state and detecting
signs of cerebral ischemia, used as an indication for se-
lective shunting during CEA, electroencephalography
(EEG; Micromed Inc., Treviso, Italy) is used. Prior to
starting anesthesia, EEG electrodes will be applied to the
patient’s skull and the EEG will be continuously regis-
tered during surgery.
Carotid endarterectomy (no deviation of standard of care)
A vascular surgeon or vascular trainee under supervision
will perform carotid surgery in a standardized way.
Patients will receive 5,000 IU heparin three minutes be-
fore cross-clamping the carotid artery. The decision for
a venous, prosthetic or bovine patch will be made by
preference of the surgeon. An intra-luminal shunt will
selectively be used based on TCD and/ or EEG criteria
as described in the literature [7].
Recruitment and consent
The principal investigator, who will inform individual
participants about the study, will do patient recruitment.
Informed consent will be obtained as soon as possible,but must be acquired before surgery. The patient infor-
mation letter and informed consent form are attached as
a separate document.
Withdrawal of individual subjects
Subjects can leave the study at any time for any reason if
they wish to do so without any consequences. The inves-
tigator can decide to withdraw a subject from the study
for urgent medical reasons. Any patient with incomplete
data registration can be withdrawn and replaced by a
consecutive patient.
Follow-up of subjects
Patients will receive no follow-up other than regular
follow-up procedures following carotid endarterectomy
(outpatient clinic visit combined with duplex ultrasound
of the operated carotid bifurcation).
Adverse and serious adverse events
Adverse events, serious adverse events and suspected,
unexpected, serious adverse reactions will be recorded
and reported according to the requirements of the accre-
dited medical ethical committee.
Statistical analysis
The MAP, TCD and NIRS measurements will be pre-
sented as continuous variables for both of the rando-
mized groups.
To examine the effect of either ephedrine or phenyl-
ephrine on rSO2 and VMCA an intention-to-treat analysis
will be used. For this analysis all patients that received
either ephedrine or phenylephrine will be included (both
responders and non-responders). Subsequently, a sub
analysis will be performed to compare the changes in
rSO2 and VMCA per 1 mmHg increase between patients
that received either ephedrine or phenylephrine. For this
sub analysis only the responders will be included.
To compare the relationship between the phenyleph-
rine and ephedrine group in an rSO2 and VMCA, the
Student’s t-test will be used. The relationship will be
calculated at two different time points:
 two minutes after either phenylephrine or ephedrine
administration (t2) and
 at the moment the maximum increase in blood
pressure is reached (tmax).
To determine whether the influence of phenylephrine
and ephedrine on cerebral perfusion and oxygenation
is different between patients with and without an ad-
equate functioning cerebral auto-regulation, another
subanalysis within both groups will be performed using
a Student’s t-test.
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Statistical Package for Social Sciences version 20.0 (SPSS
Inc, Chicago, Il, USA). A confidence level of less than
5% (0.05) is considered significant.Discussion
Since both phenylephrine and ephedrine have been rou-
tinely used for years and all measurements are part of
the standard of care, no side effects are expected. Fur-
thermore, there are no reports that the three-minute
modification in breathing frequency described in the
“intervention”-section is harmful. Varying breathing fre-
quencies while maintaining minute ventilation results in
larger tidal volumes and, therefore, an unchanged oxygen
uptake and carbon dioxide remove, which can be measured
using a pulse oximeter. Larger tidal volumes, however,
result in higher airway pressures during low frequency
ventilation. Inspiratory and expiratory airway pressures
in healthy lungs during 6 mL·kg-1 with a normal ventilatory
frequency of 12 min-1 are approximately 15 and 5 mmHg,
respectively. During a ventilatory frequency of 6 min-1
inspiratory and expiratory airway pressures will rise to
approximately 25 and 5 mmHg. This is comparable to
airway pressures observed during laparoscopic surgery
when the abdomen is inflated with carbon dioxide or dur-
ing surgery with the body in 20 Trendelenburg position.
Therefore, the risks for participating patients are negli-
gible and the burden minimal.
To our best knowledge this trial represents the first at-
tempt to evaluate the differential effects of phenylephrine
and ephedrine in correction of intraoperative hypotension
during CEA. If either of these drugs is shown to be super-
ior with respect to the cerebral hemodynamics, results
from our study will provide clinical trial evidence for the
management of blood pressure during CEA.Trial status
The Medical Ethics Committee (METC) of the University
Medical Center Utrecht has approved this study protocol.
The trial has already been started in October 2012; the
estimated length of the study will be six months.
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